Nancy King


	The CGS is housed within the:

Also on this site:

Newborn Screening

Research Ethics Consultation Service


	*Nancy King*

Nancy King, is Professor of Social Sciences and Health Policy at Wake Forest University School of Medicine and Director of the Program in Bioethics, Health, and Society. Previously she was Professor of Social Medicine at the University of North Carolina School of Medicine. Her scholarship focuses on bioethics and health law, with special concentration on roles and responsibilities in health care decisions, human subjects research ethics and policy, and “everyday ethics” issues. She has worked extensively on informed consent in health care and research, neonatal intensive care, the development and use of experimental technologies, international research ethics, and decision making at the end of life. Her approach to both teaching and scholarship is interdisciplinary, combining issues, approaches, literatures, and methods in order to promote critical reflection on questions of ethics and policy in health care and research. Professor King was a member of the Recombinant DNA Advisory Committee (RAC) of NIH from 1998-2002, and has since served on two RAC working groups, one on informed consent and one on clinical trial design. The Informed Consent Working Group produced a guidance document that serves as a comprehensive resource for investigators and IRBs. As a result of this experience, her current work focuses on aspects of human genetic research that raise important conceptual and empirical questions. One such project addresses the discussion of benefit in human gene transfer research. This work, in collaboration with colleagues at UNC and elsewhere, is funded by the ELSI Program of NHGRI. Project materials and publications may be found on the project website, Benefit in Gene Transfer Research.


	*Related Publications*

King, N. M. P. (in press). Genes and TS: What will they tell us? Scientific, ethical, and social implications. In Walkup, J. (ed.): AIN: Tourette Syndrome. Lippincott Williams & Wilkins.

King, N. M. P. (in press). The glass house: Assessing bioethics. In The Ethics of Bioethics. Eckenwiler, L., and Cohn, F. (Eds). Johns Hopkins University Press.

King, N. M. P., and Churchill, L. R. (in press). Assessing and comparing potential benefits and risks of harm. In Oxford Textbook of Clinical Research Ethics, Emanuel, E., Wendler, D., and Crouch, R. (Eds.). Oxford University Press.

Easter, M., Henderson, G., Davis, A., Churchill, L., King, N. (in press). The many meanings of care in clinical research. Reprinted in R. DeVries, L. Turner, K. Orfali & C. Bosk (Eds.), The view from here: Social science and bioethics, Oxford, UK: Blackwell Publishing Ltd.

King, N. M. P. (2007). The Ethics of Genetic Testing: Is more always better? North Carolina Medical Journal, 68 (2).

King, N. M. P. (2002). RAC oversight of gene transfer research: A model worth extending?, Journal of Law, Medicine & Ethics, 30, 381-389.

Henderson, G. W, and King, N. M. P. (2001). Studying benefit in gene transfer research, IRB: Ethics and Human Research, 23(2), 13-15.

King, N. M. P. (2000). Defining and describing benefit appropriately in clinical trials, Journal of Law, Medicine & Ethics, 28, 332-343.

King, N. M. P., Henderson, G. E., & Stein, J. (1999). Eds.: Beyond Regulations: Ethics in Human Subjects Research, University of North Carolina Press .

Churchill, L. R., Collins, M. L., King, N. M. P., Pemberton, S., and Wailoo, K. (1998). Genetic research as therapy: Implications of “gene therapy” for informed consent, Journal of Law, Medicine and Ethics, 26, 38-47.

King, N. M. P. (1996). Making Sense of Advance Directives (revised ed.), Georgetown University Press.

[Home] [About the Center] [People] [Research Activities] [Ethics and Policy] [Training] [Outreach] [Publications] [External Links]

The Center for Genomics and Society is supported by the ELSI Research Program of the National Human Genome Research Institute of the National Institutes of Health, Grant Number P50HG004488.